Hayward, CA – Aqtual Inc. has announced the appointment of Ferhan Qureshi as Chief Technology Officer. About Aqtual Inc.: Aqtual Inc. is a precision medicine company whose mission is to revolutionize chronic disease and oncology management by bridging the translational gap between groundbreaking research and practical healthcare solutions. Using proprietary biochemistry, novel technology, and advanced data science, Aqtual builds a comprehensive catalog of disease specific clinical features and develops highly accurate blood tests for disease detection, monitoring, and patient stratification across chronic inflammatory conditions and cancer. The company has achieved a major breakthrough by discovering a way to measure epigenetics, gene regulation, and transcriptomics solely from analyzing cell free DNA in a single blood draw, capturing circulating chromatin fragments that are largely inaccessible through standard laboratory methods. By leveraging these circulating chromatin signals, Aqtual is creating a novel catalog of tissue, disease, and drug specific targets in multiple therapeutic areas, positioning itself at the forefront of next generation diagnostic and precision medicine technologies. Headquartered in Hayward, California, Aqtual presents itself as a science driven organization focused on translating cutting edge molecular insights into practical tools that improve how chronic diseases and oncology are detected, managed, and treated.

For more information visit: https://aqtual.com/

Aqtual Inc.
31145 San Antonio St.
Hayward, CA 94544
Phone: 341-208-8569
LinkedIn: https://www.linkedin.com/company/aqtual/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved